Teva Upgraded at J.P. Morgan on Upcoming Catalysts
Seeking AlphaMar 8 10:21 ET
Teva Pharmaceutical Indus Analyst Ratings
BenzingaMar 8 08:11 ET
Teva Pharmaceutical Indus Analyst Ratings
BenzingaFeb 12 05:27 ET
Teva Pharmaceutical Indus Analyst Ratings
BenzingaFeb 5 08:45 ET
UBS Remains a Buy on Teva Pharmaceutical (TEVA)
TipRanksFeb 1 04:25 ET
Teva Pharmaceutical Indus Analyst Ratings
BenzingaJan 29 07:03 ET
Barclays Remains a Buy on Teva Pharmaceutical (TEVA)
TipRanksJan 29 05:07 ET
Teva Pharmaceutical Indus Analyst Ratings
BenzingaJan 23 05:53 ET
BofA Securities Adjusts Teva Pharmaceutical Industries Price Target to $14 From $13, Maintains Buy Rating
MT NewswiresJan 12 10:00 ET
Teva Pharmaceutical Indus Analyst Ratings
BenzingaJan 3 04:43 ET
HSBC Initiates Coverage On Teva Pharmaceutical Indus With Buy Rating, Announces Price Target of $13
BenzingaDec 18, 2023 08:07 ET
Teva Pharmaceutical Indus Analyst Ratings
BenzingaDec 18, 2023 08:05 ET
Teva Pharmaceutical Indus Analyst Ratings
BenzingaNov 27, 2023 05:41 ET
Alvotech Upgraded at Citi Citing FDA Nod for Biosimilars
Seeking AlphaOct 20, 2023 10:25 ET
UBS Maintains Neutral on Teva Pharmaceutical Indus, Raises Price Target to $11
BenzingaSep 20, 2023 09:08 ET
Teva Pharmaceutical Indus Analyst Ratings
BenzingaSep 20, 2023 09:07 ET
B of A Securities Maintains Buy on Teva Pharmaceutical Indus, Raises Price Target to $13
BenzingaSep 8, 2023 11:26 ET
Teva Pharmaceutical Indus Analyst Ratings
BenzingaSep 8, 2023 11:25 ET
Bank of America Securities Sticks to Their Buy Rating for Teva Pharmaceutical (TEVA)
TipRanksAug 3, 2023 06:35 ET
Teva Upgraded to Neutral at UBS on Gross Margin Recovery
Seeking AlphaJul 6, 2023 08:26 ET
No Data
No Data